The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020

Regulation 4

SCHEDULE 1 E+W Information to be contained in pharmaceutical needs assessments

Current provision of pharmaceutical services E+W

1.  A statement of the pharmaceutical services that the Local Health Board has identified as services that are provided—

(a) in the area of the Local Health Board and which are necessary to meet the need for pharmaceutical services in its area,

(b) outside the area of the Local Health Board but which nevertheless contribute towards meeting the need for pharmaceutical services in its area (if the Local Health Board has identified such services), or

(c) in or outside the area of the Local Health Board and, whilst not being services of the types described in sub-paragraph (a) or (b), they nevertheless affect the assessment by the Local Health Board of the need for pharmaceutical services in its area.

Commencement Information

I1 Sch. 1 para. 1 in force at 1.10.2020, see reg. 1(2)(b)

Other NHS services E+W

2.  A statement of any NHS services provided or arranged by the Local Health Board, another Local Health Board, a dispensing doctor or NHS Trust to which the Local Health Board has had regard in its assessment, which affect the need for pharmaceutical services, or pharmaceutical services of a specified type, in its area.

Commencement Information

I2 Sch. 1 para. 2 in force at 1.10.2020, see reg. 1(2)(b)

Gaps in provision of pharmaceutical services E+W

3.  A statement of the pharmaceutical services that the Local Health Board has identified (if it has) as services that are not provided in the area of the Local Health Board but which the Local Health Board is satisfied—

(a) need to be provided (whether or not they are located in the area of the Local Health Board) in order to meet a current need for pharmaceutical services, or pharmaceutical services of a specified type, in its area;

(b) will, in specified future circumstances, need to be provided (whether or not they are located in the area of the Local Health Board) in order to meet a future need for pharmaceutical services, or pharmaceutical services of a specified type, in its area.

Commencement Information

I3 Sch. 1 para. 3 in force at 1.10.2020, see reg. 1(2)(b)

How the assessment was carried out E+W

4.  An explanation of how the assessment has been carried out, and in particular—

(a) how it has determined what are the localities in its area,

(b) how it has taken into account (where applicable)—

(i) the different needs of different localities in its area, and

(ii) the different needs of members of different groups in its area who share a common attribute in respect of one, or more than one, of the following characteristics—

(aa) age,

(bb) gender,

(cc) proposed, commenced or completed reassignment of gender,

(dd) disability,

(ee) race,

(ff) religion or belief, and

(gg) sexual orientation;

(c) a report on the consultation that it has undertaken.

Commencement Information

I4 Sch. 1 para. 4 in force at 1.10.2020, see reg. 1(2)(b)

Map of provision E+W

5.  A map that identifies the premises at which pharmaceutical services and dispensing services are provided in the area of the Local Health Board.

Commencement Information

I5 Sch. 1 para. 5 in force at 1.10.2020, see reg. 1(2)(b)